HLA-B rs2523679: Cancer Risk and Ancestral Genetics
The genetic variant rs2523679 is a single nucleotide polymorphism located in the human leukocyte antigen (HLA) complex near the HLA-B gene on chromosome 6. Research has identified this variant as a cross-ancestral marker associated with susceptibility to oropharyngeal carcinoma. Because evidence remains limited, it serves primarily as an indicator of statistical immune-mediated risk rather than a direct clinical diagnosis.
What each genotype means
Typical HLA-B profile
This genotype represents the most common ancestral state at this position in the HLA-B gene. Research indicates that individuals with this genotype do not carry the specific variant associated with increased risk for oropharyngeal carcinoma in certain cohorts. This finding should be interpreted in the context of your overall health and family history.
This is the most common genotype globally, found in the vast majority of individuals across all major ancestral groups.
Increased risk marker
Carrying one copy of this variant has been associated with a statistically higher risk for oropharyngeal carcinoma in specific European and admixed ancestry populations. Because this association is based on limited evidence and complex HLA locus interactions, it is not a diagnostic indicator of disease. Please discuss these findings with your healthcare provider to understand how they relate to your personal health profile.
This genotype is observed in a significant portion of the population, with frequencies varying between 10% and 25% depending on specific ancestral backgrounds.
Elevated risk marker
Carrying two copies of this variant is associated with the highest statistical risk for oropharyngeal carcinoma identified in studies of European and admixed ancestry cohorts. While this association is consistent in research, it remains a marker of susceptibility rather than a clinical diagnosis. You should consult with a medical professional to discuss appropriate screening and health monitoring based on your complete clinical picture.
This genotype is less common than the heterozygous state but is present at measurable frequencies in populations where the variant is prevalent.
Genetic Location and Nature of the Variant
The single nucleotide polymorphism rs2523679 is located within the major histocompatibility complex (MHC) on the short arm of chromosome 6 (6p21.33), situated in the genomic region of the HLA-B gene. The MHC is one of the most genetically dense, polymorphic, and structurally intricate regions in the entire human genome. Nucleotide variations in this locus frequently capture extended ancestral haplotypes through strong linkage disequilibrium with classical HLA class I alleles. As an ancestral variant, rs2523679 tracks specific historical lineages of immune-modulating alleles across human populations. Cataloged in major public resources such as dbSNP and Ensembl, rs2523679 provides geneticists with a reliable tag for investigating immune response heterogeneity.
Biological Function of the HLA-B Gene
The HLA-B gene encodes a cell-surface glycoprotein that constitutes part of the classical major histocompatibility complex (MHC) class I presentation system. HLA class I molecules are expressed across nearly all nucleated human cells and serve as essential sentinels of the adaptive immune system. Their biological role is to bind endogenously derived peptide fragments—such as viral antigens, cellular debris, or aberrant tumor neoantigens—and display them on the outer cell membrane. When presenting these antigens, HLA-B interacts directly with cytotoxic CD8+ T cells and natural killer (NK) cells. If an presented peptide is recognized as foreign or aberrant, the immune system triggers targeted apoptosis of the affected cell, offering protection against infections and preventing early oncogenic transformation.
Research Associations and Evidence Strength
Genome-wide association studies (GWAS) and head and neck cancer genetic analyses have implicated the HLA region in susceptibility to oropharyngeal squamous cell carcinoma, especially types linked to oncogenic viruses like human papillomavirus (HPV). Variant rs2523679 has been identified as a cross-ancestral marker conferring a consistent risk association with oropharyngeal carcinoma across European and admixed ancestry cohorts. However, the overall clinical evidence strength remains classified as limited. Complex patterns of linkage disequilibrium in the MHC make it difficult to determine whether rs2523679 directly affects molecular function or merely tags another causal classical HLA-B allele. Further multi-ancestry fine-mapping and functional studies are necessary before this marker can be used in routine clinical stratification.
Population Frequency and Diversity
According to the Genome Aggregation Database (gnomAD), the minor allele frequency (MAF) of rs2523679 ranges generally between 0.10 and 0.25 across admixed American and European ancestry populations. Because the human leukocyte antigen region has evolved under intense natural selection driven by infectious pathogens, allele distributions differ markedly between geographic and ancestral groups. The variant is well-represented in both admixed and continental European cohorts, demonstrating cross-ancestral conservation in its genomic architecture. The broad distribution of rs2523679 underscores that carrying the risk-associated allele is a common biological occurrence rather than a rare pathogenic mutation.
Interpreting Results and Clinical Perspective
Discovering an association with rs2523679 on a personal genetic report does not diagnose or predict oropharyngeal cancer. Head and neck malignancies are multifactorial diseases influenced significantly by environmental and lifestyle factors, primarily persistent HPV infection, tobacco use, and alcohol consumption. A statistical risk variant confers only a modest shift in relative susceptibility, not an inevitable clinical outcome. Furthermore, while certain HLA-B alleles influence severe cutaneous adverse drug reactions (such as SJS/TEN with carbamazepine), rs2523679 is not an established pharmacogenomic dosing marker. Readers evaluating personal health or screening strategies should discuss any concerns with a qualified healthcare provider rather than relying on direct-to-consumer genetic variants.
How common is this variant?
According to population datasets including gnomAD, the minor allele frequency of rs2523679 ranges between approximately 0.10 and 0.25 across admixed American and European ancestry groups.
Frequently asked questions
What does rs2523679 indicate about my health?
The variant rs2523679 is a genetic marker near the HLA-B gene that has shown a modest statistical association with oropharyngeal carcinoma risk in population studies. It is not a diagnostic test and cannot determine whether an individual will develop cancer.
Does carrying the rs2523679 risk allele mean I will get oropharyngeal cancer?
No. The vast majority of people with risk-associated alleles at rs2523679 never develop head or neck cancers. Environmental factors such as HPV exposure, smoking, and alcohol consumption have a much stronger influence on cancer development than this single genetic marker.
Is rs2523679 used for medication dosing or drug safety?
No. While other specific classical alleles of the HLA-B gene (such as HLA-B*15:02 or HLA-B*57:01) guide clinical drug safety, rs2523679 has no approved pharmacogenomic guidelines. Patients should always consult a physician or pharmacist before altering any prescribed therapy.
Why is the evidence for rs2523679 described as limited?
The HLA complex is characterized by extensive linkage disequilibrium, meaning many neighboring variants are inherited together. Because of this complexity, researchers have not yet definitively established whether rs2523679 itself alters cellular function or is merely tagging another causal genetic variation nearby.
Sources & further reading
Educational information only, last refreshed 9/7/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2523679?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in HLA-B
This variant is located in the HLA-B region and is associated with immune response variability and susceptibility to various autoimmune conditions.
Variant in the HLA-B locus associated with immune response and inflammatory disease susceptibility.
Variant residing within the human leukocyte antigen complex associated with autoimmune disorders and differential immune response.
Variant in the HLA-B region associated with immune response and drug hypersensitivity reactions.
This SNP is located in the 3' region of the HLA-B gene and is associated with HIV-1 controller phenotypes.
Located in the HLA-B region, this marker is associated with viral load set points and HIV-1 disease progression.